UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

Signal transduction and targeted therapy, 2020-10, Vol.5 (1), p.249-249, Article 249

2020

Volltextzugriff (PDF)

Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion

Gut, 2020-01, Vol.69 (1), p.122

2020

Volltextzugriff (PDF)

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies

Immunological reviews, 2012-03, Vol.246 (1), p.359-378

2012

Volltextzugriff (PDF)

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies

Therapeutic Advances in Medical Oncology, 2015-03, Vol.7 (2), p.68-84

2015

Volltextzugriff (PDF)

Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022

Cancers, 2022-02, Vol.14 (5), p.1249

2022

Volltextzugriff (PDF)

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis

Genes & development, 2007-07, Vol.21 (14), p.1714-1719

2007

Volltextzugriff (PDF)

RALA and RALBP1 regulate mitochondrial fission at mitosis

Nature cell biology, 2011-09, Vol.13 (9), p.1108

2011

Volltextzugriff (PDF)

Oncogenically active MYD88 mutations in human lymphoma

Nature (London), 2011-02, Vol.470 (7332), p.115-119

2011

Volltextzugriff (PDF)

A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma

The oncologist (Dayton, Ohio), 2021-09, Vol.26 (9), p.722-726

2021

Volltextzugriff (PDF)

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

Clinical cancer research, 2017-04, Vol.23 (7), p.1748-1759

2017

Volltextzugriff (PDF)

Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models

Molecular cancer therapeutics, 2018-10, Vol.17 (10), p.2144-2155

2018

Volltextzugriff (PDF)

Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?

The oncologist (Dayton, Ohio), 2012-02, Vol.17 (2), p.192-200

2012

Volltextzugriff (PDF)

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

Cancers, 2021-10, Vol.13 (21), p.5481

2021

Volltextzugriff (PDF)

The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (18), p.7561-7569

2008

Volltextzugriff (PDF)

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

Nature communications, 2024-03, Vol.15 (1), p.2503-18, Article 2503

2024

Volltextzugriff (PDF)

Current biologics for treatment of biliary tract cancers

Journal of gastrointestinal oncology, 2017-06, Vol.8 (3), p.430-440

2017

Volltextzugriff (PDF)

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

Cancer cell, 2005-11, Vol.8 (5), p.381-392

2005

Volltextzugriff (PDF)

Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion

Cancers, 2021-03, Vol.13 (6), p.1283

2021

Volltextzugriff (PDF)

Toll-like receptor signaling

Cold Spring Harbor perspectives in biology, 2013-01, Vol.5 (1), p.a011247-a011247

2013

Volltextzugriff (PDF)

Pancreatic cancer survival analysis defines a signature that predicts outcome

PloS one, 2018-08, Vol.13 (8), p.e0201751

2018

Volltextzugriff (PDF)

Activation of RalA is critical for Ras-induced tumorigenesis of human cells

Cancer cell, 2005-06, Vol.7 (6), p.533-545

2005

Volltextzugriff (PDF)

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects

World journal of gastroenterology : WJG, 2021-05, Vol.27 (18), p.2105-2121

2021

Volltextzugriff (PDF)

Distinct clinical and magnetic resonance features of metastatic hepatocellular carcinoma treated with pembrolizumab: A case report of late response after pseudoprogression

Hepatology communications, 2018-02, Vol.2 (2), p.148-151

2018

Volltextzugriff (PDF)

CC Chemokine Receptor 2‑Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma

ACS nano, 2021-01, Vol.15 (1), p.1186-1198

2021

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(136)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(54)
Humans
(42)
Oncology
(36)
Animals
(24)
Pancreatic Cancer
(22)
Tumors
(18)
Mice
(17)
Adenocarcinoma
(16)
Cell Line, Tumor
(15)
Chemotherapy
(15)
Pancreatic Neoplasms - Pathology
(15)
Cell Biology
(12)
Proteins
(12)
Cancer
(11)
Female
(10)
Gastroenterology & Hepatology
(10)
Medical Prognosis
(10)
Mutation
(10)
Pancreatic Neoplasms - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies

Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis

RALA and RALBP1 regulate mitochondrial fission at mitosis

Oncogenically active MYD88 mutations in human lymphoma

A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma

Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models

Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities

The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

Current biologics for treatment of biliary tract cancers

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion

Toll-like receptor signaling

Pancreatic cancer survival analysis defines a signature that predicts outcome

Activation of RalA is critical for Ras-induced tumorigenesis of human cells

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects

Distinct clinical and magnetic resonance features of metastatic hepatocellular carcinoma treated with pembrolizumab: A case report of late response after pseudoprogression

CC Chemokine Receptor 2‑Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma

Suchergebnisse filtern